---
title: "Clearone Drops 10% After-Hours on Merger Deal with Cortigent"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291980228.md"
description: "Clearone (CLRO) tumbles 10% after-hours to $12.49 following merger announcement with Cortigent, after surging 98% in regular trading."
datetime: "2026-07-07T21:31:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291980228.md)
  - [en](https://longbridge.com/en/news/291980228.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291980228.md)
---

# Clearone Drops 10% After-Hours on Merger Deal with Cortigent

Clearone(CLRO.US) 盘后跌**9.75%**，现报**12.49**美元。

公司日前宣布与 Vivani Medical 旗下子公司 Cortigent 达成并购协议，交易完成后 Clearone 将更名为 Cortigent Holdings，股票代码变更为 CRGT。Vivani 股东预计将持有合并后实体**59.4%-67.5%**的股权， Concurrently 融资计划拟筹集**1000 万至 1500 万**美元。交易预计于 2026 年第三季度完成。

受并购消息推动，CLRO 在 07/07/2026 正则交易时段曾大涨**97.71%**，成交量显著放大。盘后时段出现获利回吐压力，股价回调。

### Related Stocks

- [CLRO.US](https://longbridge.com/en/quote/CLRO.US.md)

## Related News & Research

- [ClearOne files draft information statement for Cortigent merger share issuance](https://longbridge.com/en/news/293076104.md)
- [ClearOne Disclosed Failure to Satisfy a Continued Listing Rule or Standard](https://longbridge.com/en/news/282586606.md)
- [ClearOne enters loan agreement with First Finance for up to $1 million at 11% interest](https://longbridge.com/en/news/291458334.md)
- [ClearOne enters merger deal to acquire Vivani unit Cortigent](https://longbridge.com/en/news/291841889.md)
- [Vivani Medical: Buy Rating Reaffirmed as Novo Nordisk Evaluation and Cortigent–ClearOne Merger Support $3.50 Price Target](https://longbridge.com/en/news/292224424.md)